D821 | Èä¼±¼º ¸²ÇÁÁ¶Á÷¹«Çü¼º | Thymic alymphoplasia |
|
D821 | ¸é¿ª°áÇÌÀ» µ¿¹ÝÇÑ Èä¼±¹«Çü¼º ¶Ç´Â Çü¼ºÀúÇÏ | Thymic aplasia or hypoplasia with immunodeficiency |
|
D822 | ªÀº»çÁöü±¸¸¦ µ¿¹ÝÇÑ ¸é¿ª°áÇÌ | Immunodeficiency with short-limbed stature |
|
D823 | ¿¦½ºÅ¸ÀÎ-¹Ù¸£¹ÙÀÌ·¯½º¿¡ ´ëÇÑ À¯Àü¼º °á¼Õ¹ÝÀÀ¿¡ µû¸¥ ¸é¿ª°áÇÌ | Immunodeficiency following hereditary defective response to Epstein-Barr virus |
|
D823 | X-¿¬°ü ¸²ÇÁÁõ½Ä¼º Áúȯ | Immunodeficiency following hereditary defective response to Epstein-Barr virus |
|
D824 | °í¸é¿ª±Û·Îºí¸° EÁõÈıº | Hyperimmunoglobulin E[lgE] syndrome |
|
D828 | ±âŸ ¸í½ÃµÈ ÁÖ¿ä °á¼Õ°ú °ü·ÃµÈ ¸é¿ª°áÇÌ | Immunodeficiency associated with other specified major defects |
|
D829 | »ó¼¼ºÒ¸íÀÇ ÁÖ¿ä °á¼Õ°ú °ü·ÃµÈ ¸é¿ª°áÇÌ | Immunodeficiency associated with major defect, unspecified |
|
D83 | °øÅë°¡º¯¼º ¸é¿ª°áÇÌÁõ | Common variable immunodeficiency |
|
D830 | B¼¼Æ÷ ¼ö ¹× ±â´ÉÀÇ ÇöÀúÇÑ ÀÌ»ó¿¡ ÀÇÇÑ °øÅë °¡º¯¼º ¸é¿ª°áÇÌ | Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function |
|
D831 | ÇöÀúÇÑ ¸é¿ªÁ¶ÀýT¼¼Æ÷ Àå¾Ö¿¡ ÀÇÇÑ °øÅë°¡º¯¼º ¸é¿ª°áÇÌ | Common variable immunodeficiency with predominant immunoregulatory T-cell disorders |
|
D832 | B ¶Ç´Â T¼¼Æ÷¿¡ ´ëÇÑ ÀÚ°¡Ç×ü¸¦ µ¿¹ÝÇÑ °øÅë °¡º¯¼º ¸é¿ª°áÇÌ | Common variable immunodeficiency with autoantibodies to B-or T-cells |
|
D838 | ±âŸ °øÅë°¡º¯¼º ¸é¿ª°áÇÌ | Other common variable immunodeficiencies |
|
D839 | »ó¼¼ºÒ¸íÀÇ °øÅë°¡º¯¼º ¸é¿ª°áÇÌ | Common variable immunodeficiency, unspecified |
|
D84 | ±âŸ ¸é¿ª°áÇÌ | Other immunodeficiencies |
|
D840 | ¸²ÇÁ±¸±â´ÉÇ׿ø-1°á¼Õ | Lymphocyte function antigen-1 [LFA-1] defect |
|
D841 | º¸Ã¼°èÅëÀÇ°á¼Õ | Defects in the complement system |
|
D841 | C1¿¡½ºÅÍ·¹À̽º ¾ïÁ¦ÀÎÀÚ°áÇÌ | C1 esterase inhibitor[C1-INH] dificiency |
|
D848 | ±âŸ ¸í½ÃµÈ ¸é¿ª°áÇÌ | Other specified immunodeficiencies |
|
D849 | »ó¼¼ºÒ¸íÀÇ ¸é¿ª°áÇÌ | Immunodeficiency, unspecified |
|